Stop ferrous sulfate immediately—a ferritin of 1,428 µg/L indicates iron overload, not deficiency.
Clinical Assessment Required
Your patient has iron overload, not iron deficiency. With a ferritin of 1,428 µg/L, continuing oral iron supplementation is inappropriate and potentially harmful. The critical first step is determining the underlying cause of this elevated ferritin.
Immediate Actions
- Discontinue ferrous sulfate 325 mg BID immediately 1, 2
- Measure transferrin saturation (TSAT) to distinguish between true iron overload versus ferritin elevation from inflammation 1, 3
- Check inflammatory markers (CRP, ESR) since ferritin is an acute phase reactant and can be falsely elevated in inflammation, infection, or malignancy 3
Diagnostic Algorithm
If TSAT >45-50% with ferritin >1,000 µg/L:
- This suggests true iron overload (hereditary hemochromatosis or secondary iron overload)
- Check HFE gene mutation analysis (C282Y and H63D) 1
- Consider liver function tests and assess for end-organ damage 1
- Initiate phlebotomy therapy with target ferritin 50-100 µg/L 1, 4, 5
If TSAT <20-30% with elevated ferritin:
- This pattern suggests inflammatory iron block rather than true overload 3
- Investigate underlying inflammatory conditions (chronic infection, autoimmune disease, malignancy)
- Iron supplementation remains contraindicated until inflammation resolves 3
Why Continuation is Harmful
Iron supplementation above ferritin 500 µg/L risks toxicity, particularly in children and adolescents 6. The ESPEN guidelines explicitly state that "iron supplementation in the presence of normal or even high ferritin values is not recommended and is potentially harmful" 2.
For hemochromatosis specifically, the American Association for the Study of Liver Diseases recommends avoiding iron supplements entirely and targeting ferritin levels of 50-100 µg/L through phlebotomy 1. Even in chronic kidney disease patients receiving erythropoietin, guidelines suggest monitoring to prevent ferritin from exceeding 500 µg/L 6.
Common Pitfalls to Avoid
- Do not assume anemia equals iron deficiency: Anemia with high ferritin suggests anemia of chronic disease, not iron deficiency 3
- Do not continue iron "to finish the prescription": Each 325 mg ferrous sulfate tablet contains 65 mg elemental iron—continuing adds unnecessary iron burden 7
- Do not wait to investigate: Ferritin >1,000 µg/L in hemochromatosis patients warrants evaluation for cirrhosis and other complications before initiating phlebotomy 1
Monitoring After Discontinuation
Recheck ferritin and TSAT in 4-8 weeks after stopping iron supplementation 8. Do not recheck sooner, as circulating iron from recent supplementation interferes with accurate assessment 8. If ferritin remains >1,000 µg/L with elevated TSAT, proceed with hemochromatosis workup and consider phlebotomy therapy 1, 5.
The target ferritin for maintenance in treated hemochromatosis is 50-100 µg/L, though more relaxed targets (<200 µg/L in women, <300 µg/L in men) may be acceptable in elderly patients during maintenance phase 5.